The 30% is very misleading.
None of the other companies had a CRL for landscape vs portrait and wash hands after use.... The threat of a new reason for CRL is almost non existent.
That being said, the SP can do whatever it likes up to and post approval.
Im waiting for the big pharma buyout .... or BOT to hit 5% market. Let's see how long that takes. Will they pay dividends ?
current share price represents 3000 sufferers at pe 36:1, with 50% margin on 700 usd a unit.
That is 0.08 of 1% of the market.
Times by 10, and we are still not at 1% or Kakens sales year 2 after entering Japanese market with same product
Where will we be in 12 months time?, page-103
-
- There are more pages in this discussion • 153 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.005(1.43%) |
Mkt cap ! $627.0M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 36.0¢ | 34.5¢ | $1.255M | 3.601M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 206282 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 316320 | 5 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |